205 related articles for article (PubMed ID: 35189566)
1. Generation of an induced pluripotent stem cell line (EURACi014-A) from a Parkinson's disease patient with an A53T mutation in the SNCA gene by an integration-free reprogramming method.
Gilmozzi V; Gentile G; Riekschnitz DA; Volpato CB; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
Stem Cell Res; 2022 Apr; 60():102713. PubMed ID: 35189566
[TBL] [Abstract][Full Text] [Related]
2. Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.
Lee SY; Jeong S; Kim J; Chung SK
Stem Cell Res; 2018 Jul; 30():145-149. PubMed ID: 29906669
[TBL] [Abstract][Full Text] [Related]
3. Generation of TWO G51D SNCA missense mutation iPSC lines (CRICKi011-A, CRICKi012-A) from two individuals at risk of Parkinson's disease.
Devito LG; Zanjani ZS; Evans JR; Scardamaglia A; Houlden H; Gandhi S; Healy L
Stem Cell Res; 2023 Sep; 71():103134. PubMed ID: 37336145
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
[TBL] [Abstract][Full Text] [Related]
5. Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA.
Barbuti PA; Santos BFR; Dording CM; Cruciani G; Massart F; Hummel A; Krüger R
Stem Cell Res; 2020 Oct; 48():101951. PubMed ID: 32798915
[TBL] [Abstract][Full Text] [Related]
6. Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant.
Kozhushko N; Beilina A; Cookson MR
Stem Cell Res; 2023 Jun; 69():103125. PubMed ID: 37229975
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human induced pluripotent stem cell line derived from a Parkinson's disease patient carrying SNCA duplication.
Suzuki H; Egawa N; Kondo T; Imamura K; Enami T; Tsukita K; Suga M; Shibukawa R; Okanishi Y; Uchiyama T; Inoue H; Takahashi R
Stem Cell Res; 2020 May; 45():101828. PubMed ID: 32413791
[TBL] [Abstract][Full Text] [Related]
8. Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P.
Barbuti P; Antony P; Santos B; Massart F; Cruciani G; Dording C; Arias J; Schwamborn J; Krüger R
Cells; 2020 Sep; 9(9):. PubMed ID: 32927687
[TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation.
Wang Y; Wei C; Liu Y; Lu X; Wang W; Song N; Zhang W; Xu J; Zhang W; Han F
Stem Cell Res; 2024 Jun; 77():103359. PubMed ID: 38460235
[TBL] [Abstract][Full Text] [Related]
10. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
11. Modeling Parkinson's disease using induced pluripotent stem cells.
Byers B; Lee HL; Reijo Pera R
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
13. Generation of three clones (JUCGRMi002-A, B, C) of induced pluripotent stem cells from a Parkinson's disease patient with SNCA duplication.
Ishikawa KI; Shiga T; Yoshino H; Nishioka K; Hattori N; Akamatsu W
Stem Cell Res; 2024 Feb; 74():103296. PubMed ID: 38154385
[TBL] [Abstract][Full Text] [Related]
14. Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene.
Zanon A; Riekschnitz D; von Troyer M; Volpato C; Picard A; Cantaloni C; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I
Stem Cell Res; 2019 Dec; 41():101624. PubMed ID: 31715428
[TBL] [Abstract][Full Text] [Related]
15. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene.
Lu X; Song N; Wang W; Liu Y; Song H; Xu L; Wang Y; Wei C; Chen J; Yang X; Han F
Stem Cell Res; 2021 Oct; 56():102514. PubMed ID: 34464855
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
17. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
[TBL] [Abstract][Full Text] [Related]
18. Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.
Singh Dolt K; Hammachi F; Kunath T
Brain Pathol; 2017 Jul; 27(4):545-551. PubMed ID: 28585381
[TBL] [Abstract][Full Text] [Related]
19. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
20. Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson's disease.
Zafar F; Nallur Srinivasaraghavan V; Yang Chen M; Alejandra Morato Torres C; Schüle B
Stem Cell Res; 2022 Apr; 60():102733. PubMed ID: 35263701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
